Disease & disorder

pancreatic adenocarcinoma

MONDO:0006047

A carcinoma that arises from glandular epithelial cells of the pancreas

Clinical trials53
Recruiting19
Drug concepts studied20
Synonyms6

Research intelligence

Directly mapped studies only · unique clinical trials

Current registry observations. Phase counts may overlap. Study start dates are not registry registration dates. Investigational interventions are not approved-treatment recommendations.

Medications under investigation

Verified disease and drug mappings that co-occur within the same study; not evidence of effectiveness.

Loading mapped interventions…

MONDO disease family

Loading verified ontology relationships…

Recruiting studies by city

Loading research-site locations…

Trial status

Loading…

Trial phase

Loading…

Study start year

Loading…

Investigated drug interventions

Loading…
Background context

pancreatic adenocarcinoma

Wikidata Q18556189 ↗
Background only. Canonical identity remains MONDO; clinical-trial relationships come from ClinicalTrials.gov.

Clinical trials

40 shown
Evaluation of XYA02 in Patients With Advanced Solid TumorsNCT07670312 · 2026-09-17
RECRUITING
TCR1188-ABC Cells in KRAS-mutated CancersNCT07594067 · 2026-08-01
RECRUITING
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid TumorsNCT07488676 · 2026-05-04
RECRUITING
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid TumorsNCT07349537 · 2026-01-08
RECRUITING
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid TumorsNCT07090499 · 2025-08-20
RECRUITING
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H MutationNCT06778863 · 2025-02-28
RECRUITING
THE-0504 in Patients With Solid TumorsNCT07646106 · 2024-11-13
RECRUITING
Safety and Efficacy of BA1302 in Patients With Advanced Solid TumorsNCT06596915 · 2024-09-11
RECRUITING
This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid TumorsNCT06451497 · 2024-05-22
RECRUITING
Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Patients With Taxans-resistant Pancreatic Adenocarcinoma, Cholangiocarcinoma, Lung Cancer, Gastric Cancer, Esophageal Carcinoma, or Breast CancerNCT06199895 · 2023-11-28
RECRUITING
Analyzing and Solving Exceptional Long-term Survivors in Solid Tumors With Poor PrognosisNCT06160596 · 2023-11-01
RECRUITING
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H MutationNCT05877599 · 2023-07-12
RECRUITING
Study to Assess GTAEXS617 in Participants With Advanced Solid TumorsNCT05985655 · 2023-07-06
RECRUITING
A Study of PF-08046054/SGN-PDL1V in Advanced Solid TumorsNCT05208762 · 2022-10-25
RECRUITING
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP DeletionNCT05245500 · 2022-06-09
RECRUITING
Atezolizumab Plus Tivozanib in Immunologically Cold Tumor TypesNCT05000294 · 2021-12-07
RECRUITING
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy EvaluationNCT05059444 · 2021-09-07
RECRUITING
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid TumorsNCT04895709 · 2021-05-27
RECRUITING
Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid TumorsNCT03740256 · 2020-12-14
RECRUITING
A Phase Ⅰ Study of CS08399 in Participants With MTAP-deleted Solid Tumors and LymphomaNCT07583771 · 2026-06-01
NOT_YET_RECRUITING
A Study of SGN-MesoC2 in Advanced Solid TumorsNCT06466187 · 2024-08-02
TERMINATED
A Study to Investigate APL-5125 in Adults With Advanced Solid TumorsNCT06399757 · 2024-06-18
COMPLETED
Multicenter Trial of ESK981 in Patients With Select Solid TumorsNCT05988918 · 2024-04-19
ACTIVE_NOT_RECRUITING
A Study of IMM-6-415 in RAS/RAF Mutant Solid TumorsNCT06208124 · 2024-02-27
COMPLETED
Study of RO7515629 in Participants With HLA-G Positive Solid TumorsNCT05769959 · 2023-06-15
TERMINATED
Study of LP-184 in Patients With Advanced Solid TumorsNCT05933265 · 2023-06-09
ACTIVE_NOT_RECRUITING
A Study to Evaluate the Safety and Dosimetry of 68Ga-labelled OncoFAP Derivatives in Solid TumorsNCT05784597 · 2023-04-27
COMPLETED
A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid TumorsNCT05795595 · 2023-03-13
COMPLETED
Study of MRTX1133 in Patients With Advanced Solid Tumors Harboring a KRAS G12D MutationNCT05737706 · 2023-03-06
TERMINATED
Study of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid TumorsNCT05651022 · 2023-02-28
ACTIVE_NOT_RECRUITING
A Trial of Cobicistat and Gemcitabine and Nab-Paclitaxel in Patients with Advanced Stage or Metastatic Pancreatic Ductal AdenocarcinomaNCT05494866 · 2022-12-07
TERMINATED
A Phase 1/2a Study of IMM-1-104 in Participants With Advanced or Metastatic Solid TumorsNCT05585320 · 2022-10-31
ACTIVE_NOT_RECRUITING
Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic CancerNCT05620134 · 2022-10-17
ACTIVE_NOT_RECRUITING
A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing CancerNCT05451849 · 2022-06-21
TERMINATED
Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing TumorsNCT04802876 · 2021-04-12
ACTIVE_NOT_RECRUITING
KEBI-Cyto Study - Use of the Biocartis IdyllaNCT04236102 · 2020-07-07
COMPLETED
Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer.NCT03983954 · 2019-10-10
ACTIVE_NOT_RECRUITING
The Occurence of Pancreatic Cancer Studied in Association With Newly Diagnosed Diabetes in the ElderlyNCT04164602 · 2019-10-09
UNKNOWN
GB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic AdenocarcinomaNCT04060342 · 2019-08-13
TERMINATED
9-ING-41 in Patients With Advanced CancersNCT03678883 · 2019-01-04
ACTIVE_NOT_RECRUITING

Disease identity and terminology: MONDO. Trial relationships: ClinicalTrials.gov.